EMERALD: Elacestrant in ER+/HER2- Advanced Breast Cancer : v

Kevin Kalinsky, MD, MS, gives an overview of recent data from the EMERALD trial investigating elacestrant in patients with ER+/HER2- advanced breast cancer.

Related Keywords

Kevin Kalinsky , , Breast Cancer , Hr Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatment , Esr1 , Esr1 Mutations , Emerald Study , Emerald Trial , Elacestrant ,